Hepatocarcinogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Roles of Interleukin-10 and Transcriptomic Insights into IL-10 Signaling Rewiring. This evidence concerns the gene IL10 and metabolic dysfunction-associated steatotic liver disease.